GCP
AKYA

GSA Capital Partners’s Akoya BioSciences AKYA Stock Holding History

GSA Capital Partners’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-180,734
Closed -$414K – 1608
2024
Q4 		$414K Sell
180,734
-129,935
-42% -$344K 0.03% 1014
2024
Q3 		$845K Buy
310,669
+144,903
+87% +$354K 0.06% 579
2024
Q2 		$388K Buy
165,766
+150,001
+951% +$478K 0.03% 1125
2024
Q1 		$74K Buy
+15,765
New +$81.9K 0.01% 1514

Other funds holding AKYA

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

GSA Capital Partners's AKYA Position: Q1 2025 in Review

GSA Capital Partners sold out of Akoya BioSciences (AKYA) in Q1 2025, closing a stake of 180,734 shares — an estimated $414K sold.

GSA Capital Partners first reported a position in AKYA in Q1 2024 and held it in 4 quarters. The position peaked at $845K in Q3 2024. 64 funds tracked by Wall St. Rank hold AKYA as of Q1 2025.

  • GSA Capital Partners reported no remaining Akoya BioSciences position as of Q1 2025 after selling out during the quarter.
  • GSA Capital Partners sold 180,734 Akoya BioSciences shares in Q1 2025, an estimated $414K.
  • GSA Capital Partners first reported a position in Akoya BioSciences in Q1 2024 and held it in 4 quarters.
  • GSA Capital Partners's Akoya BioSciences position peaked at $845K in Q3 2024.
  • 64 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2025.

Based on GSA Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.